검색어 : 통합검색[Horn Norbert]
총 148건 중 148건 출력
, 13/15 페이지
-
121
- A whole genome scan for differences in recombination rates among three Bos taurus breeds
- Thomsen, Hauke; Reinsch, Norbert; Xu, Ningying; Bennewitz, Jö rn; Looft, Christian; Grupe, Sven; Kü hn, Christa; Brockmann, Gudrun A.; Schwerin, Manfred; Leyhe-Horn, Birgit; Hiendleder, Stefan; Erhardt, Georg; Medjugorac, Ivica; Russ, Ingolp; Fö rster, Martin; Brenig, Bertram; Reinhardt, Fritz; Reents, Reinhard; Blü mel, Jü rgen; Averdunk, Gottfried; Kalm, Ernst; ; (Mammalian genome : official journal of the International Mammalian Genome Society, v.12, 2001, pp.724-728)
-
122
- The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL
- Horn, Heike; Ziepert, Marita; Barth, Thomas F.E.; Bernd, Heinz-Wolfram; Wartenberg, Martin; Feller, Alfred C.; Klapper, Wolfram; Hummel, Michael; Stein, Harald; Lenze, Dido; Hartmann, Sylvia; Hansmann, Martin-Leo; Mö ller, Peter; Cogliatti, Sergio; Pfreundschuh, Michael; Trü mper, Lorenz; Lö ffler, Markus; Ott, German; Schmitz, Norbert; Rosenwald, Andreas; Clinical Pharmacology, Dr. Margarete Fischer Bosch Institute and University of Tuebingen, Stuttgart, Germany,; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany,; Department of Pathology, University Medical Center Ulm, Ulm, Germany,; Institute of Pathology, University Hospital Schleswig-Holstein, Lü beck, Germany,; Institute of Pathology, University of Wü rzburg, Wü rzburg, Germany,; Institute of Pathology, University Hospital Schleswig-Holstein, Lü beck, Germany,; Department of Hematopathology, University of Kiel, Kiel, Germany,; Department of Pathology, Charité - Universitä tsmedizin Berlin, Berlin, Germany,; Universitä tsklinikum Benjamin Franklin, Berlin, Germany,; Institute of Pathology, Campus Benjamin Franklin, Charité Universitä tsmedizin, Berlin, Germany,; Senckenberg Institute of Pathology, Goethe University, Frankfurt am Main, Germany,; Institute of Pathology, U; (Blood, v.122, 2013, pp.4262-4262)
-
123
- Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
- Hä usler, Sebastian F. M.; Montalbá n del Barrio, Itsaso; Strohschein, Jenny; Anoop Chandran, P.; Engel, Jö rg B.; Hö nig, Arnd; Ossadnik, Monika; Horn, Evi; Fischer, Birgitt; Krockenberger, Mathias; Heuer, Stefan; Seida, Ahmed Adel; Junker, Markus; Kneitz, Hermann; Kloor, Doris; Klotz, Karl-Norbert; Dietl, Johannes; Wischhusen, Jö rg; ; (Cancer immunology, immunotherapy : CII, v.60, 2011, pp.1405-1418)
-
124
- CD8<SUP>+</SUP> T-Cell Response Promotes Evolution of Hepatitis C Virus Nonstructural Proteins
- Ruhl, Marianne; Knuschke, Torben; Schewior, Kevin; Glavinic, Lejla; Neumann-Haefelin, Christoph; Chang, Dae-In; Klein, Marina; Heinemann, Falko M.; Tenckhoff, Hannelore; Wiese, Manfred; Horn, Peter A.; Viazov, Sergei; Spengler, Ulrich; Roggendorf, Michael; Scherbaum, Norbert; Nattermann, Jacob; Hoffmann, Daniel; Timm, Jö rg; ; (Gastroenterology, v.140, 2011, pp.2064-2073)
-
125
- The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl
- Staiger, Annette M.; Ziepert, Marita; Horn, Heike; Scott, David W.; Barth, Thomas F. E.; Bernd, Heinz-Wolfram; Feller, Alfred C.; Klapper, Wolfram; Hummel, Michael; Stein, Harald; Lenze, Dido; Hansmann, Martin-Leo; Hartmann, Sylvia; Moeller, Peter; Cogliatti, Sergio; Lenz, Georg; Truemper, Lorenz H.; Loeffler, Markus; Schmitz, Norbert; Pfreundschuh, Michael; Rosenwald, Andreas; Ott, German; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, Canada; Institute of Pathology, Universitä tsklinikum Ulm, Ulm, Germany; Haematopathology Luebeck, Luebeck, DEU; Haematopathology Luebeck, Luebeck, Germany; Hematopathology Section, Christian-Albrechts-University Kiel, Kiel, Germany; Institute of Pathology, Charité , University Medical Center, Berlin, Germany; Berlin Reference Center for Lymphoma and Hematopathology, Berlin, Germany; Institute of Pathology, Charité , University Medical Center, Berlin, Germany; Dr. Senckenberg Institute of Pathology, Goethe University Hospital of Frankfurt Main, Frankfurt, Germany; Dr. Senckenberg Institute of Pathology, Goethe University Hospital of Frankfurt; (Blood, v.128, 2016, pp.151-151)
-
126
- Clinical Impact of the Cell-of-Origin Classification and the <i>MYC</i>/<i>BCL2</i> Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
- Staiger, Annette M.; Ziepert, Marita; Horn, Heike; Scott, David W.; Barth, Thomas F.E.; Bernd, Heinz-Wolfram; Feller, Alfred C.; Klapper, Wolfram; Szczepanowski, Monika; Hummel, Michael; Stein, Harald; Lenze, Dido; Hansmann, Martin-Leo; Hartmann, Sylvia; Mö ller, Peter; Cogliatti, Sergio; Lenz, Georg; Trü mper, Lorenz; Lö ffler, Markus; Schmitz, Norbert; Pfreundschuh, Michael; Rosenwald, Andreas; Ott, German; Annette M. Staiger, Heike Horn, and German Ott, Institute of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart; Annette M. Staiger and Heike Horn, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; Annette M. Staiger and Heike Horn, University of Tuebingen, Tuebingen; Marita Ziepert and Markus Lö ffler, Institute for Medical Informatics, Statistics and Epidemiology, Universitä t Leipzig, Leipzig; Thomas F.E. Barth and Peter Mö ller, Institute of Pathology, Universitä tsklinikum...; Annette M. Staiger, Heike Horn, and German Ott, Institute of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart; Annette M. Staiger and Heike Horn, Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; Annette M. Staiger and Heike Horn, University of Tuebingen, Tuebingen; Marita Ziepert and Markus Lö ffler, Institute for Medical Informatics, Statistics and Epidemiology, Universitä t Leipzig, Leipzig; Thomas F.E. Barth and Peter M&; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.2515-2526)
-
127
- Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA
- Kurz, Katrin S.; Steinlein, Sophia; Kreuz, Markus; Ziepert, Marita; Staiger, Annette M.; Barth, Thomas F. E.; Mö ller, Peter; Bernd, Heinz‐ Wolfram; Feller, Alfred C.; Richter, Julia; Klapper, Wolfram; Stein, Harald; Hartmann, Sylvia; Hansmann, Martin‐ Leo; Trü mper, Lorenz; Loeffler, Markus; Schmitz, Norbert; Rosenwald, Andreas; Ott, German; Horn, Heike; Department of Clinical Pathology Robert‐ Bosch‐ Krankenhaus Stuttgart Germany; Dr. Margarete Fischer‐ Bosch‐ Institute of Clinical Pharmacology Stuttgart and University of Tü bingen Tü bingen Germany; Institute for Medical Informatics, Statistics, and Epidemiology Universitä t Leipzig Leipzig Germany; Institute for Medical Informatics, Statistics, and Epidemiology Universitä t Leipzig Leipzig Germany; Department of Clinical Pathology Robert‐ Bosch‐ Krankenhaus Stuttgart Germany; Institute of Pathology Universitä tsklinikum Ulm Ulm Germany; Institute of Pathology Universitä tsklinikum Ulm Ulm Germany; Hematopathology Lü beck Germany; Hematopathology Lü beck Germany; Institute of Pathology, Hematopathology Section and Lymph Node Registry, Universitä tsklinikum Schleswig‐ Holstein, Campus Kiel Kiel Germany; Institute of Pathology, Hematopathology Section and Lymph Node Registry, Universitä tsklinik; (Hemasphere : Open access journal of the european hematology association, v.9, 2025, pp.e70093)
-
128
- A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
- Staiger, Annette M.; Altenbuchinger, Michael; Ziepert, Marita; Kohler, Christian; Horn, Heike; Huttner, Michael; Hü ttl, Katrin S.; Glehr, Gunther; Klapper, Wolfram; Szczepanowski, Monika; Richter, Julia; Stein, Harald; Feller, Alfred C.; Mö ller, Peter; Hansmann, Martin-Leo; Poeschel, Viola; Held, Gerhard; Loeffler, Markus; Schmitz, Norbert; Trü mper, Lorenz; Pukrop, Tobias; Rosenwald, Andreas; Ott, German; Spang, Rainer; ; (Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, v.34, 2020, pp.543-552)
-
129
- Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
- Paul, Ulrike; Richter, Julia; Stuhlmann-Laiesz, Christiane; Kreuz, Markus; Nagel, Inga; Horn, Heike; Staiger, Annette M.; Aukema, Sietse M.; Hummel, Michael; Ott, German; Spang, Rainer; Rosenwald, Andreas; Feller, Alfred C.; Cogliatti, Sergio; Stein, Harald; Hansmann, Martin-Leo; Moller, Peter; Szczepanowski, Monika; Burkhardt, Birgit; Pfreundschuh, Michael; Schmitz, Norbert; Loeffler, Markus; Trü mper, Lorenz; Siebert, Reiner; Klapper, Wolfram; Institute of Human Genetics, Christian-Albrecht University, Kiel, Germany; ; Institute of Human Genetics, Christian-Albrecht University, Kiel, Germany; ; Hematopathology Section, Christian-Albrecht University, Kiel, Germany; ; Institute for Medical Informatics, Statistics and Epidemiology University of Leipzig, Leipzig, Germany; ; Institute of Human Genetics, Christian-Albrecht University, Kiel, Germany; ; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; ; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; ; Hematopathology Section, Christian-Albrecht University, Kiel, Germany; ; Institute of Pathology, Campus Benjamin Franklin, Charité Universitä tsmedizin, Berlin, Germany; ; Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany; ; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany; ; Institute of Pathology, University Wü rzburg and Comprehensive Cancer Main; (Leukemia & lymphoma, v.59, 2018, pp.1213-1221)
-
130
- Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
- Ott, German; Ziepert, Marita; Klapper, Wolfram; Horn, Heike; Szczepanowski, Monika; Bernd, Heinz-Wolfram; Thorns, Christoph; Feller, Alfred C.; Lenze, Dido; Hummel, Michael; Stein, Harald; Mü ller-Hermelink, Hans-Konrad; Frank, Matthias; Hansmann, Martin-Leo; Barth, Thomas F. E.; Mö ller, Peter; Cogliatti, Sergio; Pfreundschuh, Michael; Schmitz, Norbert; Trü mper, Lorenz; Loeffler, Markus; Rosenwald, Andreas; Institute of Pathology, University of Wü rzburg, Wü rzburg, Germany; ; Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany; ; Institute of Hematopathology and Lymph Node Registry, Universitä tsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany; ; Institute of Pathology, Robert-Bosch Hospital and Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; ; Institute of Hematopathology and Lymph Node Registry, Universitä tsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany; ; Institute of Pathology, Universitä tsklinikum Schleswig-Holstein, Campus Lü beck, Lü beck, Germany; ; Institute of Pathology, Universitä tsklinikum Schleswig-Holstein, Campus Lü beck, Lü beck, Germany; ; Institute of Pathology, Universitä tsklinikum Schleswig-Holstein, Campus Lü beck, Lü beck, Germany; ; Institute of Pathology, Campus Benjamin Franklin, Charité Universit&a; (Blood, v.116, 2010, pp.4916-4925)
QUICK MENU
